Albany Molecular Wins $37 Million NIH Contract

Wednesday, January 21, 2015

Source: Times Union

Albany Molecular Research Inc., the Albany-based drug-manufacturer, has won a 10-year contract with the National Institutes of Health to make drugs for clinical trials for neurological disease.

AMRI can be awarded up to $37.3 million under the contract.

It’s been a busy month for AMRI. The company announced last week that it will make generic drugs for Genovi Pharmaceuticals Ltd.

On Jan. 9, AMRI announced the acquisition of a Scotland manufacturing facility and an Indiana lab from a drug discovery service company called Aptuit for $60 million.

View All News »